Changqing Xie

Also affiliated with Shaoyang University, National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 36 papers. Top paper: “A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma”.

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

The Oncologist(2022)10.1093/oncolo/oyab073

N/A

1.5DataRank · unranked

44 citations

Erica C. Pehrsson, Changqing Xie, Austin G. Duffy, Donna Mabry, Bradford J. Wood +10 more

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005640

N/A

1.4DataRank · unranked

72 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang +15 more

Lineage and ecology define liver tumor evolution in response to treatment

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101394

N/A

0.503DataRank · unranked

11 citations

Limin Wang, Marshonna Forgues, Shay Behrens, Amanda J. Craig, Meng Liu +9 more

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008079

N/A

0.470DataRank · unranked

11 citations

Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J. Wood +7 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma

Cancer Medicine(2024)10.1002/cam4.6912

N/A

0.450DataRank · unranked

12 citations

Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Gagandeep Brar +12 more

A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.117

N/A

0DataRank · unranked

19 citations

Changqing Xie, Seth M. Steinberg, Suzanne Fioraventi, Melissa Walker, Donna Mabry‐Hrones +4 more

Phase II study of nivolumab (anti-PD1), tadalafil, and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4656

N/A

0DataRank · unranked

4 citations

Changqing Xie, Donna Mabry‐Hrones, Bradford J. Wood, Seth M. Steinberg, David E. Kleiner +2 more

Long-term survival of combined ablation therapy and tremelimumab with or without durvalumab in advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16689

N/A

0DataRank · unranked

1 citations

Changqing Xie, John C. McVey, Donna Mabry‐Hrones, Austin G. Duffy, Bradford J. Wood +2 more

Immune Checkpoint Inhibitor Associated Hepatotoxicity in Primary Liver Cancer Versus Other Cancers: A Systematic Review and Meta‐Analysis

Frontiers in Oncology(2021)10.3389/fonc.2021.650292

N/A

0DataRank · unranked

48 citations

Wang‐Zhong Li, Nicole McGrath, Chunwei W. Lai, Gagandeep Brar, Yan‐Qun Xiang +2 more

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s311496

N/A

0DataRank · unranked

18 citations

Changqing Xie, Seth M. Steinberg, Tim F. Greten, Cecilia Monge

Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD

Cancer Cell(2022)10.1016/j.ccell.2022.08.004

N/A

0DataRank · unranked

111 citations

Qiong Fu, Laurence P. Diggs, John C. McVey, Justin McCallen, Simon Wabitsch +17 more

Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance

Cancers(2022)10.3390/cancers14020381

N/A

0DataRank · unranked

50 citations

Jihye Lee, Changqing Xie, Xin Wang

Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma

Hepatobiliary & pancreatic diseases international(2022)10.1016/j.hbpd.2022.03.006

N/A

0DataRank · unranked

15 citations

Nicole McGrath, Jihye Lee, Xin Wang, Gagandeep Brar, Changqing Xie +1 more

Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing

Stem Cells International(2022)10.1155/2022/3558200

N/A

0DataRank · unranked

16 citations

Jianyang Fu, Xin Wang, Jihye Lee, Gagandeep Brar, Freddy E. Escorcia +3 more

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.849958

N/A

0DataRank · unranked

10 citations

Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W. Lai, Amanda J. Craig +6 more

Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials

Journal of biomedical science and research(2022)10.36266/jbsr/164

N/A

0DataRank · unranked

5 citations

Hoyoung Maeng, J Lee, Changqing Xie, Xue Wang

In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy

Nature Communications(2023)10.1038/s41467-023-36045-7

N/A

0DataRank · unranked

74 citations

Samantha Stewart, Alisa White, Elyahb Allie Kwizera, Jiangsheng Xu, Yuanzhang Fang +8 more

The current landscape of therapies for hepatocellular carcinoma

Carcinogenesis(2023)10.1093/carcin/bgad052

N/A

0DataRank · unranked

28 citations

Changqing Xie, Donna Mabry Hrones, Shadin Ghabra, Tim F. Greten, Cecilia Monge +1 more

Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101052

N/A

0DataRank · unranked

31 citations

Erica C. Pehrsson, Aiwu Ruth He, Lipika Goyal, Robin Kate Kelley, Hien Dang +26 more

Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex

Nature Communications(2023)10.1038/s41467-023-39374-9

N/A

0DataRank · unranked

28 citations

Simone A. Baechler, Xiaohu Zhang, Suresh Kumar, Valentina M. Factor, Yasuhiro Arakawa +20 more

Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma

Cancers(2023)10.3390/cancers15092454

N/A

0DataRank · unranked

13 citations

Xin Wang, Jing Bian, Benjamin Ruf, Michael E. Kelly, Baktiar Karim +3 more

Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression

Frontiers in Cell and Developmental Biology(2023)10.3389/fcell.2023.1250215

N/A

0DataRank · unranked

8 citations

Jing Bian, Xin Wang, Jianyang Fu, Xiao Bin Zhu, Julie Yeo +5 more

Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1124066

N/A

0DataRank · unranked

5 citations

Shu‐Hui Lv, Guoying Liu, Nian Lu, Yaofei Jiang, Hu L +5 more

Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics

Cells(2023)10.3390/cells12060862

N/A

0DataRank · unranked

12 citations

Xin Wang, Hoyoung Maeng, Changqing Xie, Jihye Lee

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma

JHEP Reports(2023)10.1016/j.jhepr.2023.100723

N/A

0DataRank · unranked

10 citations

Benjamin L. Green, Changqing Xie, Chao Liu, Xin Chen, Xinjun Lu

Reciprocal Interaction of Cancer Stem Cells of Cholangiocarcinoma with Macrophage

Stem Cell Reviews and Reports(2023)10.1007/s12015-023-10557-7

N/A

0DataRank · unranked

10 citations

Jihye Lee, Nga Voong Hawk, Changqing Xie, Xin Wang

A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps624

N/A

0DataRank · unranked

18 citations

M. Cecilia Monge B., Donna Mabry‐Hrones, Kelley Coffman, Stephanie N. Hicks, Bernadette Redd +5 more

Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16158

N/A

0DataRank · unranked

2 citations

Kelley Coffman, Donna Mabry Hrones, Seth M. Steinberg, Bernadette Redd, Bradford J. Wood +3 more

Primary liver cancer organoids and their application to research and therapy

Journal of the National Cancer Center(2024)10.1016/j.jncc.2024.06.002

N/A

0DataRank · unranked

8 citations

Rajiv Trehan, Changqing Xie, Xiaobin Zhu

The Gut Microbiome Controls Liver Tumors via the Vagus Nerve

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.23.576951

N/A

0DataRank · unranked

15 citations

Rajiv Trehan, Benjamin Ruf, Yuta Myojin, Mohamed-Reda Benmebarek, Chi Ma +20 more

Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3624

N/A

0DataRank · unranked

101 citations

Austin G. Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry‐Hrones, Melissa Walker +14 more

Altering the gut microbiome and tumor microenvironment in advanced liver cancer: A phase II study of nivolumab, tadalafil and oral vancomycin in patients with refractory primary hepatocellular carcinoma or liver dominant metastatic cancer from colorectal or pancreatic cancers

Cancer Letters(2025)10.1016/j.canlet.2025.217975

N/A

0DataRank · unranked

3 citations

Joy Awosika, Cecilia Monge, Kelley Coffman, Changqing Xie, Nebojša Skorupan +13 more

Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.045

N/A

0DataRank · unranked

59 citations

Shu‐Hui Lv, Guoying Liu, Hu L, Xiang Guo, Xing Lv +8 more

Systemic treatment options for advanced biliary tract carcinoma

Journal of Gastroenterology(2020)10.1007/s00535-020-01712-9

N/A

0DataRank · unranked

22 citations

Nicole McGrath, Cecilia Monge Bonilla, Jianyang Fu, Changqing Xie

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Hepatoma Research(2020)10.20517/2394-5079.2020.58

N/A

0DataRank · unranked

10 citations

Nicole McGrath, Jianyang Fu, Changqing Xie, Cecilia Monge Bonilla

Targeting cancer stem cells in cholangiocarcinoma (Review)

International Journal of Oncology(2020)10.3892/ijo.2020.5074

N/A

0DataRank · unranked

24 citations

Jianyang Fu, Sophie Z. Gu, Changqing Xie, Nicole McGrath